Hydromorphone Hydrochloride | Suppliers | Impurities | Impurity Standards| PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Hydromorphone Hydrochloride
Others

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

xyz-pharma-2025-04-21

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Hydromorphone Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 11 USDMF, 7 CEP/COS, 1 JDMF, 2 KDMF, 22 NDC API, 9 Listed Suppliers, $ API Reference Price

36 API Suppliers
11 USDMF
7 CEP/COS
1 JDMF
2 KDMF
22 NDC API
9 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

219 FDF Dossiers, 76 FDA Orange Book, 36 Europe, 42 Canada, 40 Australia, 5 South Africa, 20 Listed Dossiers

219 FDF Dossiers
76 FDA Orange Book
36 Europe
42 Canada
40 Australia
5 South Africa
20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.2MG/ML, INJECTABLE;INJECTION - 0.5MG/0.5ML, INJECTABLE;INJECTION - 10MG/ML, INJECTABLE;INJECTION - 1MG/ML, INJECTABLE;INJECTION - 2MG/ML, INJECTABLE;INJECTION - 4MG/ML, SOLUTION;ORAL - 5MG/5ML, TABLET;ORAL - 2MG, TABLET;ORAL - 4MG, TABLET;ORAL - 8MG, TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 32MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.2MG/ML
INJECTABLE;INJECTION - 0.5MG/0.5ML
INJECTABLE;INJECTION - 10MG/ML
INJECTABLE;INJECTION - 1MG/ML
INJECTABLE;INJECTION - 2MG/ML
INJECTABLE;INJECTION - 4MG/ML
SOLUTION;ORAL - 5MG/5ML
TABLET;ORAL - 2MG
TABLET;ORAL - 4MG
TABLET;ORAL - 8MG
TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 32MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 2 Rochem International Inc, 15 SPI Pharma, 6 DKSH, 4 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 26 BASF, 1 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 24 Roquette, 12 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 35 Controlled & Modified Release, 32 Direct Compression, 28 Film Formers & Plasticizers, 28 Solubilizers, 27 Thickeners and Stabilizers, 26 Parenteral, 24 Granulation, 20 Disintegrants & Superdisintegrants, 19 Topical, 19 Taste Masking, 18 Lubricants & Glidants, 17 Co-Processed Excipients, 14 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 7 API Stability Enhancers, 6 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

86 Fillers, Diluents & Binders
56 Coating Systems & Additives
35 Controlled & Modified Release
32 Direct Compression
28 Film Formers & Plasticizers
28 Solubilizers
27 Thickeners and Stabilizers
26 Parenteral
24 Granulation
20 Disintegrants & Superdisintegrants
19 Topical
19 Taste Masking
18 Lubricants & Glidants
17 Co-Processed Excipients
14 Chewable & Orodispersible Aids
8 Emulsifying Agents
7 API Stability Enhancers
6 Rheology Modifiers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 58 News #PharmaBuzz

2 Data Compilation #PharmaFlow
58 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 46 Regulatory FDF Prices

2 US Medicaid Prescriptions
46 Regulatory FDF Prices

MARKET PLACE

1 APIs, 2 FDF Dossiers

1 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 1 US Exclusivities, 12 Health Canada Patents

14 US Patents
1 US Exclusivities
12 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 5 Others

2 EDQM
5 Others

$ API Ref.Price (USD/KG) : 7,574 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

5 All

01 2Mallinckrodt Pharmaceuticals

02 3USP

filter CAS Number Reset all filters

5 All

01 1109648-80-8(base)

02 171-68-1

03 191265-67-7

04 2Blank

filter Details Reset all filters

5 All

01 1Material Origin- Chemical Synthesis; USMCA- No; KORUS- Yes; Base Control Drug- HYDROM ORPHON E; Base Control Drug %- 84.47

02 1Material Origin- Chemical Synthesis; USMCA- No; KORUS- Yes; Base Control Drug- HYDROM ORPHON E; Base Control Drug %- 89

03 1Material Origin- Chemical Synthesis; USMCA- Yes; KORUS- Yes; Base Control Drug- MORPHIN E; Base Control Drug %- 74.35

04 2Blank

filter Country Reset all filters

5 All

01 3Gabon

02 2Ireland

Product Main Page

01

Mallinckrodt Pharmaceuticals

Iran Expo

Not Confirmed

Mallinckrodt Pharmaceuticals

Iran Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydromorphone Base ARS

CAS Number :

Quantity Per Vial :

Sale Unit :

Price :

Details :

Monograph :

Storage :

Code/Batch No : 1233

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Mallinckrodt Pharmaceuticals

Iran Expo

Not Confirmed

Mallinckrodt Pharmaceuticals

Iran Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydromorphone HCl ARS

CAS Number :

Quantity Per Vial :

Sale Unit :

Price :

Details :

Monograph :

Storage :

Code/Batch No : 1234

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

XYZ Pharma

Iran Expo

Not Confirmed

XYZ Pharma

Iran Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Virtual Booth

Digital Content

Hydromorphone Hydrochloride CII (50 mg)

CAS Number : 71-68-1

Quantity Per Vial : 50

Sale Unit : mg

Price : $325.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1323000 / K1I330

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Corporate PDF

04

XYZ Pharma

Iran Expo

Not Confirmed

XYZ Pharma

Iran Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Virtual Booth

Digital Content

Hydromorphone N- Oxide Hydrochloride CII (15 ...

CAS Number : 109648-80-8(base)

Quantity Per Vial : 15

Sale Unit : mg

Price : $814.00

Details : Material Origin- Chemical Synthesis; USMCA- N...

Monograph :

Storage :

Code/Batch No : Catalog #1323019 / F1I331

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Corporate PDF

05

XYZ Pharma

Iran Expo

Not Confirmed

XYZ Pharma

Iran Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Virtual Booth

Digital Content

Hydromorphone Related Compound A CII (10 mg) ...

CAS Number : 91265-67-7

Quantity Per Vial : 10

Sale Unit : mg

Price : $814.00

Details : Material Origin- Chemical Synthesis; USMCA- Y...

Monograph :

Storage :

Code/Batch No : Catalog #1323021 / R086C0

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!